Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer

Fig. 1

Association of S100A11 gene expression with the survival and clinical features of gastric cancer patients. The survival analysis of S100A11 (probe_ID: 200660_at) was conducted on the KMPlot (https://kmplot.com). a Overall survival (OS). b Post progression survival (PPS). c First progress survival (FP). The association of S100A11 and the clinicopathological features of GC was analysed using the TCGA data. d Tumour vs normal. e Metastasis status. M0: no metastasis; M1: with metastasis. Mx: unknown metastasis status. f Lymph node metastasis stages. g Tumour stages. h Gender. The difference between the two groups was analysed using the Wilcoxon test, while the Kruskal–Wallis test was used to compare the difference among multiple groups

Back to article page